eXoZymes to Host Fourth Quarter and Full Year 2024 Results Conference Call on Wednesday April 2, 2025
press releaseIPOinvestor
eXoZymes to Host Fourth Quarter and Full Year 2024 Results Conference Call on Wednesday April 2, 2025March 26, 2025
Fox Business: Interview with Chief Market Strategist, Lou Basenese
investorpress clippingsvideo
Fox Business: Interview with Chief Market Strategist, Lou BaseneseMarch 17, 2025
Fox Business: Interview with CEO Michael Heltzen
heltzeninvestorpress clippingsvideo
Fox Business: Interview with CEO Michael HeltzenMarch 3, 2025
Edgardo Rayo, new member of the Board of Directors at eXoZymes Inc.
press releaseinvestorARCHIVE
ARCHIVE: eXoZymes and MDB Capital Announce Leadership Transition at eXoZymes Inc.February 21, 2025
ARCHIVE: Watch eXoZymes' Nasdaq closing bell ceremony
heltzeninvestorvideoARCHIVE
ARCHIVE: Watch eXoZymes' Nasdaq closing bell ceremonyFebruary 20, 2025
eXoZymes Announces Nasdaq Bell Ringing to Commemorate Initial Public Offering on Feb 19, 2025
press releaseIPOinvestorARCHIVE
ARCHIVE: Nasdaq Bell Ringing to Commemorate Initial Public OfferingFebruary 19, 2025
ARCHIVE: GEN Edge: What’s in a Name - Out with Invizyne, In with eXoZymes
press clippingsARCHIVE
ARCHIVE: GEN Edge: What’s in a Name - Out with Invizyne, In with eXoZymesFebruary 15, 2025
ARCHIVE: Creating value for partners through exozyme biosolutions
investorvideo
ARCHIVE: Creating value for partners through exozyme biosolutionsFebruary 12, 2025
ARCHIVE: The difference between enzymes and exozymes: Explaining our tech
investorvideoARCHIVE
ARCHIVE: The difference between enzymes and exozymes: Explaining our techFebruary 12, 2025
ARCHIVE: Vision: What's the potential impact of exozymes?
investorvideoARCHIVE
ARCHIVE: Vision: What's the potential impact of exozymes?February 12, 2025
Previous page
Page 7 of 11
Next page